Using Fluorescence Microscopy to Identify a Potential New Treatment for Heart Failure by Himes, Ryan D.
USING FLUORESCENCE MICROSCOPY 
TO IDENTIFY A POTENTIAL 
NEW TREATMENT FOR 
HEART FAILURE
Dr. Ryan Himes
Assistant Professor of Biological Sciences, Olivet Nazarene University

Why Study Heart Failure?
 Heart failure = cardiac output that is insufficient 
to meet the demands of the body.
 Affects 6.5 million US adults (~3% of pop.)
 1 in 8 deaths has heart failure mentioned on 
death certificate.1
 Digoxin causes an increase in cardiac  
contraction strength, but has a narrow 
therapeutic window.2
1. AHA 2017 Statistical Update, Circulation, 135:e378-e384.
2. Bers, DM.  EC Coupling and Cardiac Contractile Force, 2001.
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Approach for Screening Mutants:
Measuring Binding Affinity with FRET
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HEK cells co-transfected with 
CFP-NKA and PLM-
Cell line courtesy of Dr. Julie Bossuyt (UC Davis)

FRET Eff. (%) = FRETmax*[Protein]n / (KDn + [Protein]n) 
Measuring Binding Affinity with FRET
0 20 40 60
0
20
40
60
F
R
E
T
 
E
f
f
i
c
i
e
n
c
y
 
(
%
)
[Protein] (AU)
I18A
G19A
G20A
L21A
I22A
I23A
G25A
I26A
L27A
F28A
I29A
L30A
G31A
I32A
L33A
I34A
V35A
L36A
S37A
S63A/S68A
S63E/S68E
WT
0 6 12 18
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Loss of NKA BindingGain of NKA Binding
KD2 (arbitrary units)
P
L
M
 
M
u
t
a
n
t
*
KD
KD
10 µm
PLM-YFP
WGA-Ax594
Overlay
Video courtesy of Dan Blackwell
0 3 6 9
0.4
0.5
0.6
I
n
d
o
-
1
 
R
a
t
i
o
Time (sec.)
Intracellular [Ca2+]
0 3 6 9
1.66
1.68
1.70
1.72
A
v
g
.
 
S
a
r
c
o
m
e
r
e
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
Myocyte Contractions
0 1 2
1.0
1.2
1.4
1.6
GFP
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
+PLM
Intracellular [Ca2+]
Time (s)
Altamirano et al., 2006. J. Phys.
575(3):850.
0 1 2
1.0
1.2
1.4
1.6
GFP
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
+PLM
0 1 2
1.5
1.6
1.7
+PLM
GFP
S
a
r
c
.
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
Intracellular [Ca2+] Myocyte Contraction
0 1 2
1.6
1.7
L30A
 WT
S
a
r
c
.
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
0 1 2
1.0
1.1
1.2
1.3
1.4
 WT
L30A
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
Intracellular [Ca2+] Myocyte Contraction
0 1 2
1.5
1.6
1.7
L27A
A
v
g
.
 
S
a
r
c
o
m
e
r
e
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
WT
0 1 2
1.0
1.1
1.2
1.3
1.4
L27A
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
WT
Intracellular [Ca2+] Myocyte Contraction
0 1 2
1.6
1.7
I32A
WT
A
v
g
.
 
S
a
r
c
o
m
e
r
e
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
0 1 2
1.0
1.1
1.2
1.3
1.4
1.5
I32A
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
WT
Intracellular [Ca2+] Myocyte Contraction
0 1 2
1.4
1.5
1.6
1.7
S
a
r
c
.
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
L30A
WT
0 1 2
1.0
1.5
2.0
L30A
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
WT
0 1 2
1.6
1.7
L30A
 WT
S
a
r
c
.
 
L
e
n
g
t
h
 
(

m
)
Time (sec.)
0 1 2
1.0
1.1
1.2
1.3
1.4
 WT
L30A
I
n
d
o
-
1
 
F
/
F
0
Time (sec.)
Intracellular [Ca2+] Myocyte Contraction
+ adrenaline
Conclusions
 L30A PLM caused increased binding to NKA.
 L30A PLM mimics the effect of digoxin on isolated 
cardiomyocytes.
 Adrenaline relieved this effect.
 L30A PLM could be a useful therapeutic for heart 
failure.
Digoxin
Pharmacological NKA Inhibition
Physiological NKA Inhibition
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Academic Research 
Collaborations Program
In addition to providing direct-to-
consumer genetic testing through the 
23andMe® Service, 23andMe 
endeavors to advance biomedical 
science through genetic research.
Some of those discoveries have and 
will come from our own scientists, but 
others will come from collaborations 
with academic researchers external 
to 23andMe through the 23andMe 
Academic Research Collaboration 
Program.
